共 129 条
[1]
Go H(2014)Frequent detection of BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms Histopathology 65 261-272
[2]
Jeon YK(2012)High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses Blood 120 2700-2703
[3]
Huh J(2016)Somatic mutations in histiocytic sarcoma identified by next generation sequencing Virchows Arch 469 233-e41
[4]
Choi SJ(2018)Response to MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma Haematologica 103 e39-1947
[5]
Choi YD(2018)Trametinib in histiocytic sarcoma with an activating MAP2K1 (MEK1) mutation N Engl J Med. 378 1945-704
[6]
Cha HJ(2002)CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma N Engl J Med 346 235-1144
[7]
Haroche J(2010)Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era J Clin Oncol 28 4184-404
[8]
Charlotte F(2005)Histiocytic sarcoma: a study of five cases including the histiocyte marker CD163 Mod Pathol 18 693-224
[9]
Arnaud L(2004)Extranodal histiocytic sarcoma: clinicopathologic analysis of 14 cases of a rare epithelioid malignancy Am J Surg Pathol 28 1133-112
[10]
von Deimling A(1988)A clinicopathologically distinctive primary splenic histiocytic neoplasm. Demonstration of its histiocyte derivation by immunophenotypic and molecular genetic analysis Am J Surg Pathol. 12 398-359